Page 1439 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1439
6 References
198. Beall DP, Scofield RH. Milk-alkali syndrome associated with 217. Gaasbeek A, Meinders A. Hypophosphatemia: an update on its
calcium carbonate consumption. Report of 7 patients with para- etiology and treatment. Am J Med. 2005;118(10):1094-1101.
thyroid hormone levels and an estimate of prevalence among 218. Fiaccadori E, et al. Hypophosphatemia in course of chronic
patients hospitalized with hypercalcemia. Medicine (Baltimore). obstructive pulmonary disease. Prevalence, mechanisms, and
1995;74(2):89-96. relationships with skeletal muscle phosphorus content. Chest.
199. Lemann J Jr, Gray RW. Calcitriol, calcium, and granulomatous 1990;97(4):857-868.
disease. N Engl J Med. 1984;311(17):1115-1117. 219. Zazzo JF, et al. High incidence of hypophosphatemia in surgical
200. Seymour JF, et al. Calcitriol production in hypercalcemic and intensive care patients: efficacy of phosphorus therapy on myo-
normocalcemic patients with non-Hodgkin lymphoma. Ann cardial function. Intensive Care Med. 1995;21(10):826-831.
Intern Med. 1994;121(9):633-640. 220. Brunelli S, Goldfarb S. Hypophosphatemia: clinical con-
201. Stewart AF. Clinical practice. Hypercalcemia associated with sequences and management. JAm Soc Nephrol. 2007;18(7):
cancer. N Engl J Med. 2005;352(4):373-379. 1999-2003.
202. Cardella CJ, Birkin BL, Rapoport A. Role of dialysis in the treat- 221. Weinsier RL, Krumdieck CL. Death resulting from overzealous
ment of severe hypercalcemia: report of two cases successfully total parenteral nutrition: the refeeding syndrome revisited. Am
treated with hemodialysis and review of the literature. Clin J Clin Nutr. 1981;34(3):393-399.
Nephrol. 1979;12(6):285-290. 222. Marik PE, Bedigian MK. Refeeding hypophosphatemia in criti-
203. Davidson TG. Conventional treatment of hypercalcemia of cally ill patients in an intensive care unit. A prospective study.
malignancy. Am J Health Syst Pharm. 2001;58(suppl 3):S8-S15. Arch Surg. 1996;131(10):1043-1047.
204. LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide 223. Brautbar N, Leibovici H, Massry SG. On the mechanism of
for hypercalcemia: an unproven yet common practice. Ann hypophosphatemia during acute hyperventilation: evidence
Intern Med. 2008;149(4):259-263. for increased muscle glycolysis. Miner Electrolyte Metab.
205. Seymour JF, Gagel RF. Calcitriol: the major humoral media- 1983;9(1):45-50.
tor of hypercalcemia in Hodgkin's disease and non-Hodgkin’s 224. De Marchi S, et al. Renal tubular dysfunction in chronic alco-
lymphomas. Blood. 1993;82(5):1383-1394. hol abuse—effects of abstinence. N Engl J Med. 1993;329(26):
206. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1927-1934.
1996;109(2):535-539. 225. Bhan I, et al. Post-transplant hypophosphatemia: tertiary
207. O’Leary TJ, et al. The effects of chloroquine on serum 1,25- ‘hyper-phosphatoninism’? Kidney Int. 2006;70(8):1486-1494.
dihydroxyvitamin D and calcium metabolism in sarcoidosis. N 226. Schiavi S, Kumar R. The phosphatonin pathway: new insights in
Engl J Med. 1986;315(12):727-730. phosphate homeostasis. Kidney Int. 2004;65(1):1-14.
208. Adams JS, Diz MM, Sharma OP. Effective reduction in the 227. Brady HR, et al. Hypophosphatemia complicating broncho-
serum 1,25-dihydroxyvitamin D and calcium concentration in dilator therapy for acute severe asthma. Arch Intern Med.
sarcoidosis-associated hypercalcemia with short-course chloro- 1989;149(10):2367-2368.
quine therapy. Ann Intern Med. 1989;111(5):437-438. 228. Subramanian R, Khardori R. Severe hypophosphatemia.
209. Nussbaum SR, et al. Single-dose intravenous therapy with Pathophysiologic implications, clinical presentations, and treat-
pamidronate for the treatment of hypercalcemia of malig- ment. Medicine (Baltimore). 2000;79(1):1-8.
nancy: comparison of 30-, 60-, and 90-mg dosages. Am J Med. 229. Michell A, Burn D, Reading P. Central pontine myelinoly-
1993;95(3):297-304. sis temporally related to hypophosphataemia. Journal Neurol
210. Ralston SH, et al. Comparison of three intravenous bisphos- Neurosurg Psychiatry. 2003;74(6):820.
phonates in cancer-associated hypercalcaemia. Lancet. 230. Falcone N, et al. Central pontine myelinolysis induced by hypo-
1989;2(8673):1180-1182. phosphatemia following Wernicke’s encephalopathy. Neurol Sci.
211. Major P, et al. Zoledronic acid is superior to pamidronate in 2004;24(6):407-410.
the treatment of hypercalcemia of malignancy: a pooled analy- 231. Geerse D, et al. Treatment of hypophosphatemia in the intensive
sis of two randomized, controlled clinical trials. J Clin Oncol. care unit: a review. Crit Care (London, England). 2010;14(4).
2001;19(2):558-567.
232. Newman JH, Neff TA, Ziporin P. Acute respiratory failure asso-
212. Kaiser W, et al. Calcium free hemodialysis: an effective therapy ciated with hypophosphatemia. N Engl J Med. 1977;296(19):
in hypercalcemic crisis—report of 4 cases. Intensive Care Med. 1101-1103.
1989;15(7):471-474.
233. Agusti A, et al. Hypophosphatemia as a cause of failed wean-
213. Sramek V, et al. Continuous venovenous hemodiafiltration ing: the importance of metabolic factors. Crit Care Med.
(CVVHDF) with citrate anticoagulation in the treatment of a 1984;12(2):142-143.
patient with acute renal failure, hypercalcemia, and thrombocy- 234. O’Connor LR, Wheeler WS, Bethune JE. Effect of hypophos-
topenia. Intensive Care Med. 1998;24(3):262-264.
phatemia on myocardial performance in man. N Engl J Med.
214. Kempson SA, et al. Parathyroid hormone action on phosphate 1977;297(17):901-903.
transporter mRNA and protein in rat renal proximal tubules. 235. Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med.
Am J Physiol. 1995;268(4, pt 2):F784-F791.
1992;92(5):455-457.
215. Ramirez JA, et al. The absorption of dietary phosphorus and 236. Wada S, et al. A case of anorexia nervosa with acute renal failure
calcium in hemodialysis patients. Kidney Int. 1986;30(5):753-759.
induced by rhabdomyolysis; possible involvement of hypo-
216. Halevy J, Bulvik S. Severe hypophosphatemia in hospitalized phosphatemia or phosphate depletion. Intern Med. 1992;31(4):
patients. Arch Intern Med. 1988;148(1):153-155. 478-482.
Section08-O-Ref.indd 6 12/10/2014 6:08:10 PM

